ZA879458B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA879458B
ZA879458B ZA879458A ZA879458A ZA879458B ZA 879458 B ZA879458 B ZA 879458B ZA 879458 A ZA879458 A ZA 879458A ZA 879458 A ZA879458 A ZA 879458A ZA 879458 B ZA879458 B ZA 879458B
Authority
ZA
South Africa
Prior art keywords
methyl
medicaments
carbazol
imidazol
solvates
Prior art date
Application number
ZA879458A
Other languages
English (en)
Inventor
Michael Brian Tyers
Brian Tyers Michael
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA879458B publication Critical patent/ZA879458B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Connection Of Batteries Or Terminals (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
ZA879458A 1986-12-17 1987-12-17 Medicaments ZA879458B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630071A GB8630071D0 (en) 1986-12-17 1986-12-17 Medicaments

Publications (1)

Publication Number Publication Date
ZA879458B true ZA879458B (en) 1988-11-30

Family

ID=10609112

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879458A ZA879458B (en) 1986-12-17 1987-12-17 Medicaments

Country Status (18)

Country Link
US (1) US4835173A (cs)
EP (1) EP0276559B1 (cs)
JP (1) JP2732844B2 (cs)
KR (1) KR880007073A (cs)
AT (1) ATE79031T1 (cs)
AU (1) AU608794B2 (cs)
CY (1) CY1693A (cs)
DE (1) DE3780940T2 (cs)
DK (1) DK662787A (cs)
ES (1) ES2051754T3 (cs)
GB (1) GB8630071D0 (cs)
GR (1) GR3005682T3 (cs)
HK (1) HK36593A (cs)
IE (1) IE60135B1 (cs)
IL (1) IL84844A0 (cs)
NZ (1) NZ222949A (cs)
PH (1) PH25503A (cs)
ZA (1) ZA879458B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5221687A (en) * 1988-09-01 1993-06-22 Glaxo Group Limited Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
HUP0400767A2 (hu) * 2001-01-11 2004-07-28 Teva Pharmaceutical Industries Limited Javított eljárás tiszta ondansetron-hidroklorid-dihidrát előállítására
CN1665823A (zh) 2002-04-29 2005-09-07 特瓦药厂有限公司 制备1,2,3,9－四氢－9－甲基－3－[(2－甲基－1h－咪唑－1－基)甲基]－4h－咔唑－4－酮的方法
DE20320528U1 (de) * 2002-04-30 2004-09-16 Teva Pharmaceuticals Usa, Inc. Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
HU225885B1 (en) * 2002-10-17 2007-11-28 Richter Gedeon Nyrt Process for producing ondansetron hydrochlorid dihydrate of high purity
US20110034442A1 (en) * 2007-08-08 2011-02-10 Jaun Jose Legarda Ibanez Use and Methods of Use for an Antagonist of the Serotin3 Receptor (5-HT3) and a Selective Modulator of Chloride Channels for the Treatment of Addiction to or Dependence on Medicines/Drugs or Nervous System Disorders
EP3810119A2 (en) 2018-06-21 2021-04-28 Société des Produits Nestlé S.A. <sup2/>? <sub2/>?+? ?compositions and methods using a nicotinamide adenine dinucleotide (nad) precursor and at least one ketone or ketone precursor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN158970B (cs) * 1981-06-09 1987-02-28 Ici Plc
GR850219B (cs) * 1984-01-25 1985-05-23 Glaxo Group Ltd
GB8401888D0 (en) * 1984-01-25 1984-02-29 Glaxo Group Ltd Heterocyclic compounds
DE3688296T2 (de) * 1985-03-14 1993-11-04 Beecham Group Plc Arzneimittel zur behandlung von erbrechen.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.

Also Published As

Publication number Publication date
JPS63165314A (ja) 1988-07-08
EP0276559A3 (en) 1989-10-18
PH25503A (en) 1991-07-24
DE3780940T2 (de) 1992-12-24
AU608794B2 (en) 1991-04-18
IE873415L (en) 1988-06-17
CY1693A (en) 1994-01-14
HK36593A (en) 1993-04-23
DK662787D0 (da) 1987-12-16
DK662787A (da) 1988-06-18
EP0276559A2 (en) 1988-08-03
GR3005682T3 (cs) 1993-06-07
AU8261787A (en) 1988-06-23
JP2732844B2 (ja) 1998-03-30
ES2051754T3 (es) 1994-07-01
DE3780940D1 (de) 1992-09-10
GB8630071D0 (en) 1987-01-28
KR880007073A (ko) 1988-08-26
US4835173A (en) 1989-05-30
NZ222949A (en) 1997-06-24
ATE79031T1 (de) 1992-08-15
IL84844A0 (en) 1988-06-30
IE60135B1 (en) 1994-06-01
EP0276559B1 (en) 1992-08-05

Similar Documents

Publication Publication Date Title
GB8630071D0 (en) Medicaments
PH25126A (en) 1,5-diaryl-3-substituted pyrazoles pharmaceutical compositions and use
IL116203A (en) Pharmaceutical compositions for the treatment of emesis comprising (2s, 3s) -3-(2-methoxybenzylamino)-2-phenylpiperidine and ondansetron
EP0363415A4 (en) Compounds for the treatment of alzheimer&#39;s disease
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
GR3004252T3 (cs)
OA09194A (en) &#34;Insecticidal treatment and compositions therefor&#34;.
IE873414L (en) Medicament for dementia
FI896306A7 (fi) Miesten yksinkertainen, pakattu inkontinenssisuojus
HU902004D0 (en) New trombolitic preparations
IL86028A0 (en) Novel pyrrolidine-2-(1,3-dicarbonyl)derivatives,their preparation,agents containing them,and their use
IL90499A0 (en) Therapeutic uses of 2&#39;,5&#39;-oligoadenylates
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
IE873231L (en) Medicaments
AU8050587A (en) Dividable capsule
EP0495226A3 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
NZ223203A (en) Herbicidal compositions containing tetrahydrophthalimides and 1,3,5-triazin-2-yl-urea derivatives
FI882378A7 (fi) Tandlaekarens patientstol.
李虎容 et al. OCCLUSAL CONSIDERATION FOR IMPLANTS
RU1833744C (en) Device for individual taking of v,n,pozdnyakov&#39;s medicinal means
IT8919216A0 (it) Dispositivo per la cura chirurgica dell&#39;astigmatismo.
IL106709A0 (en) Therapeutic uses of 2&#39;,5&#39;-oligoadenylates
ITMI931777A0 (it) Nuovi agenti per l&#39;ossigenazione extracorporea del sangue